Drugs / Shenfu Injection
Shenfu Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04493840 | Jul 2020 → Jul 2022 | acute myocardial infarction | Beijing Anzhen Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shenfu Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04493840 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Shenfu injection, as a traditional Chinese herbal formula, can alleviate ischemia-reperfusion injury through multiple pharmacologic effects.” PMID 36822255 ↗ Feb 2023 |
| Route | Intravenous | “intravenous Shenfu injection (80mL Shenfu injection + 70mL 5% glucose injection)” PMID 36822255 ↗ Feb 2023 |